RCA helping Unique Pharmaceuticals adapt to new compounding laws

Regulatory Compliance Associates (RCA), a life-sciences consultancy, said on Thursday that its cooperative effort with Unique Pharmaceuticals will help the latter demonstrate compliance with new federal compounding industry regulations. “We’re proud to partner with Unique Pharmaceuticals as they lead the compounding pharmacy industry in demonstrating their commitment to quality,” Andrew Harrison, chief regulatory affairs officer at RCA, said. Read More »